<?xml version="1.0" encoding="iso-8859-1" ?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>Pharmalicensing.com: PR Newswire</title>
		<link>http://pharmalicensing.com/rss/</link>
		<description>Latest market and business intelligence from the leading publishers worldwide.</description>
		<language>en-us</language>
		<image>
			<title>Pharmalicensing.com: PR Newswire</title>
			<link>http://pharmalicensing.com/rss/</link>
			<url>http://pharmalicensing.com/images/pharmalicensing_logo.gif</url>
			<width>144</width>
		</image>
							<item>
				<title>Valdoxan(R), the First Melatonergic Antidepressant, Receives EU CHMP Positive Opinion for Major Depressive Disorder</title>
				<description>PARIS, November 21 /PRNewswire/ -- The first melatonergic antidepressant - Valdoxan(R)/Thymanax(R)
(agomelatine) - has received a positive opinion from the European Medicines
Agency&amp;#039;s (EMEA)...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2186</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2186</guid>
				<pubDate>Fri, 21 Nov 2008 16:09:00 +0000</pubDate>
			</item>
					<item>
				<title>Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union</title>
				<description>THOUSAND OAKS, California, November 21 /PRNewswire/ -- Amgen (Nasdaq: AMGN) today announced that the European Committee for
Medicinal Products for Human Use (CHMP) has issued a positive...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2185</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2185</guid>
				<pubDate>Fri, 21 Nov 2008 14:25:00 +0000</pubDate>
			</item>
					<item>
				<title>Health Robotics Announces $60M Investment by Devon International Group and ITOCHU Inc. in the CytoCare(TM) and i.v.Station(TM PENDING) Robots</title>
				<description>BOZEN, Italy, November 21 /PRNewswire/ -- Health Robotics today announced that it has signed a definitive agreement
with Devon International Group (DIG) and its strategic partner...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2184</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2184</guid>
				<pubDate>Fri, 21 Nov 2008 14:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Unite Defends the Right to Mesothelioma Compensation</title>
				<description>LONDON, November 21 /PRNewswire/ -- In a landmark test case in the High Court, Unite the union, has
successfully defended the rights of vulnerable asbestos victims from
insurers&amp;#039; attempts to avoid...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2183</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2183</guid>
				<pubDate>Fri, 21 Nov 2008 11:48:00 +0000</pubDate>
			</item>
					<item>
				<title>MEDICA 2008: Responsible Training Practices With Vibration Platforms</title>
				<description>HAARLEM, The Netherlands and DUSSELDORF, Germany, November 21 /PRNewswire/ -- Within the framework of this year&amp;#039;s medical fair MEDICA, the
international manufacturer of vibration machines, VibroGym...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2182</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2182</guid>
				<pubDate>Fri, 21 Nov 2008 11:30:00 +0000</pubDate>
			</item>
					<item>
				<title>Promising Clinical Data on Gen-Probe&#039;s APTIMA(R) HPV Test Presented at Major European Medical Meeting</title>
				<description>SAN DIEGO, November 21 /PRNewswire/ -- Gen-Probe&amp;#039;s (Nasdaq: GPRO) CE-marked APTIMA(R) HPV assay may be an
important new molecular tool to more accurately detect high-risk human
papillomavirus (HPV)...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2180</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2180</guid>
				<pubDate>Fri, 21 Nov 2008 08:00:00 +0000</pubDate>
			</item>
					<item>
				<title>ChemDiv and Avineuro Extend Collaboration on Alzheimer&#039;s Disease and Schizophrenia</title>
				<description>SAN DIEGO, November 21 /PRNewswire/ -- ChemDiv Inc. and Avineuro Pharmaceuticals Inc. have extended the term of
their research and development collaboration including formulation, safety
and early...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2181</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2181</guid>
				<pubDate>Fri, 21 Nov 2008 08:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Permanent International Healthcare Marketplace and Education Center Set to Open in New York City in 2013</title>
				<description>NEW YORK, November 20 /PRNewswire/ -- The world&amp;#039;s first permanent international healthcare marketplace and
education center will open in less than five years, the key players driving
the project said...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2179</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2179</guid>
				<pubDate>Thu, 20 Nov 2008 22:40:00 +0000</pubDate>
			</item>
					<item>
				<title>European Agency for the Evaluation of Medicinal Products Recommends Suspension of Marketing Authorisation for IONSYS(R)</title>
				<description>BEERSE, Belgium, November 20 /PRNewswire/ -- Janssen-Cilag International NV announced today that the Committee for
Medicinal Products for Human Use (CHMP) of the European Medicines Agency 
(EMEA) has...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2178</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2178</guid>
				<pubDate>Thu, 20 Nov 2008 17:20:00 +0000</pubDate>
			</item>
					<item>
				<title>Laureate Pharma Honored as Emerging Life Sciences Company of the Year</title>
				<description>PRINCETON, New Jersey, November 20 /PRNewswire/ -- Laureate Pharma, Inc., a full-service biopharmaceutical development and
protein production company, today announced that it has been named...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2177</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2177</guid>
				<pubDate>Thu, 20 Nov 2008 14:55:00 +0000</pubDate>
			</item>
						<atom:link href="http://pharmalicensing.com/public/news/newsmlrss" rel="self" type="application/rss+xml" />
	</channel>
</rss>
